0 CHECKOUT
DrugPatentWatch Premium Plan Product Image

DrugPatentWatch Premium Plan

  • ID: 1303221
  • May 2015
  • thinkBiotech LLC

DrugPatentWatch provides information on drug patents and their expirations. Datasets include Paragraph IV challenges, tentative approval (an indicator of generic entry), patent claim types, annual sales, patent expirations, failure to pay maintenance fees, ex parte and inter partes reexamination, interference, and disclaimers. Complete details are provided for all FDA-approved small molecule drugs. Annual sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.

The Premium Plan provides comprehensive information on all FDA-approved pharmaceutical drugs - discontinued and active, with and without patent protection or other forms of market exclusivity.

Information on failure to pay patent maintenance fees, ex parte and inter partes reexaminations, interferences, and disclaimers, can help predict when patents will be delisted, months in advance.

Paragraph IV listings indicate which drugs are facing patent challenges, and can help predict early generic entry.

A historical archive, exclusively READ MORE >

Note: Product cover images may vary from those shown

Database includes:

Sales data (top 200-selling drugs)

Impending patent expirations
Patent expiration date
Patent title and abstract
Pediatric exclusivity extensions
Patent interferences
Patent disclaimers
Patent reexaminations
Paragraph IV challenges
Download full-text patent PDF
Patent claim types (use, compound, formulation, etc.)

Search by applicant name
Search by approval date
Search by branded name
Search by generic name
Search by NDA Number
Search by patent number
Search by therapeutic class
Search by dosage type

Regulatory exclusivity
Use codes
Tenative approvals (an indicator of generic entrants)

Dynamic graphs
Historical archives

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Subscription product will be emailed to you. The title is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The subscription is accessed online through a secure website. You will receive a username and password via email to access your subscription. The subscription period is one year. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The subscription is accessed online through a secure website. You will receive a username and password via email to access your subscription. The subscription period is one year. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S